Authors
Loading...
Experimental study reveals that TRPM2 channel activation drives amyloid-beta-induced inflammation in microglial cells, highlighting a potential therapeutic target for Alzheimer's disease.
Mortadza et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: